Camber Pharmaceuticals rolls out generic Invega
Paliperidone Extended-Release Tablets is an atypical antipsychotic agent indicated for the treatment of schizophrenia and schizoaffective disorder.
Camber is introducing Paliperidone Extended-Release Tablets, which are the generic of Invega.
Paliperidone Extended-Release Tablets is an atypical antipsychotic agent indicated for the treatment of schizophrenia, treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and/or antidepressants.
[Read more: Camber launches generic Phenergan]
Paliperidone Extended- Release Tablets are available in 1.5, 3, 6 and 9 mg strengths in 30-count bottles.